Skip to main content
SURMODICS INC logo

SURMODICS INC — Investor Relations & Filings

Ticker · SRDX ISIN · US8688731004 LEI · 549300H76KXCAAGUS878 US Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2010-09-22 Director's Dealing
Country US United States of America
Listing US SRDX

About SURMODICS INC

https://www.surmodics.com/

Surmodics, Inc. provides performance-enhancing technologies for the healthcare industry, focusing on medical devices and in vitro diagnostics. The company is a leading provider of surface modification technologies, offering customized hydrophilic, hemocompatible, and drug-delivery coatings for intravascular medical devices. In addition to its coatings business, Surmodics develops and commercializes a portfolio of vascular intervention medical devices for the treatment of peripheral arterial and venous disease, including thrombectomy and radial access platforms. The company also offers end-to-end contract development and manufacturing services. Its In Vitro Diagnostics (IVD) division supplies critical chemical components for immunoassays and microarrays, aiming to enhance the sensitivity and reproducibility of diagnostic tests.

Recent filings

Filing Released Lang Actions
3 Filing
Director's Dealing
2010-09-22 English
10-Q Filing
Interim / Quarterly Report Q3 2010
2010-08-06 English
4 Filing
Director's Dealing
2010-08-03 English
4 Filing
Director's Dealing
2010-08-03 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 28, 2010. It announces the results of operations and financial condition for the quarter ended June 30, 2010, and includes a press release as an exhibit. The text indicates that the press release is furnished as Exhibit 99.1, which is typical for an earnings release announcement. The document itself does not contain detailed financial statements or comprehensive analysis but rather announces the release of quarterly results. The length of the document is 2195 characters, which is relatively short and consistent with an earnings release announcement rather than a full interim or annual report. Therefore, the appropriate classification is Earnings Release (ER).
2010-07-28 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 28, 2010, which reports changes in compensatory arrangements for certain executive officers, including salary increases and stock awards. The key section is Item 5.02, which relates to the departure, election, or appointment of directors or officers and their compensatory arrangements. There are no financial statements or detailed financial results included, and the document is not an earnings release, annual report, or interim report. It is a regulatory filing reporting management changes and compensation updates. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 5488 characters, which is sufficient for a substantive filing rather than a brief announcement or certification. Confidence is high due to the clear identification of the filing type and content.
2010-07-02 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.